Literature DB >> 11554389

Centralized databases available for describing primary brain tumor incidence, survival, and treatment: Central Brain Tumor Registry of the United States; Surveillance, Epidemiology, and End Results; and National Cancer Data Base.

F G Davis1, B J McCarthy, M S Berger.   

Abstract

Characteristics of three databases--the Central Brain Tumor Registry of the United States (CBTRUS) database; the Surveillance, Epidemiology and End Results (SEER) database; and the National Cancer Data Base (NCDB)--containing information on primary brain tumors are discussed. The recently developed population-based CBTRUS database comprises incidence data on all primary brain tumors from 11 collaborating state registries; however, follow-up data are not available. SEER, the population-based gold standard for cancer data, collects incidence and follow-up data on malignant brain tumors only. While not population-based, the NCDB identifies newly diagnosed cases and conducts follow-up on all primary brain tumors from hospitals accredited by the American College of Surgeons. The NCDB is the largest of the three databases and also contains more complete information regarding treatment of these tumors than either the SEER or CBTRUS databases. Additional strengths and limitations of each of these are described, and their judicious use for supporting research, education, and health care planning is encouraged.

Entities:  

Mesh:

Year:  1999        PMID: 11554389      PMCID: PMC1920744          DOI: 10.1093/neuonc/1.3.205

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  24 in total

1.  Prospective analysis of incidence of central nervous tumors presenting in a tertiary cancer hospital from India.

Authors:  Rakesh Jalali; Debnarayan Datta
Journal:  J Neurooncol       Date:  2007-11-15       Impact factor: 4.130

Review 2.  Prognostic utility of gene therapy with herpes simplex virus thymidine kinase for patients with high-grade malignant gliomas: a systematic review and meta analysis.

Authors:  Fei Zhao; Jinhui Tian; Lifeng An; Kehu Yang
Journal:  J Neurooncol       Date:  2014-04-23       Impact factor: 4.130

3.  Brain tumors incidences and a retrospective clinical analysis from a tertiary hospital in India.

Authors:  Ravindra Pramod Deshpande; Deepak Babu; Manas Panigrahi; Y B V K Chandra Sekhar; Phanithi Prakash Babu
Journal:  J Neurooncol       Date:  2016-06-16       Impact factor: 4.130

4.  The incidence of brainstem primitive neuroectodermal tumors of childhood based on SEER data.

Authors:  Omar Chamdine; Ghada Ahmad Saad Elhawary; Ahmad Samir Alfaar; Ibrahim Qaddoumi
Journal:  Childs Nerv Syst       Date:  2018-01-03       Impact factor: 1.475

5.  The antitumor effect of mesenchymal stem cells transduced with a lentiviral vector expressing cytosine deaminase in a rat glioma model.

Authors:  Song Fei; Xing Qi; Song Kedong; Ji Guangchun; Liu Jian; Qin Wei
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-04       Impact factor: 4.553

6.  Extent of resection and survival for oligodendroglioma: a U.S. population-based study.

Authors:  Connor J Kinslow; Andrew L A Garton; Ali I Rae; Logan P Marcus; Christopher M Adams; Guy M McKhann; Michael B Sisti; E Sander Connolly; Jeffrey N Bruce; Alfred I Neugut; Adam M Sonabend; Peter Canoll; Simon K Cheng; Tony J C Wang
Journal:  J Neurooncol       Date:  2019-08-12       Impact factor: 4.130

7.  Spinal location is prognostic of survival for solitary-fibrous tumor/hemangiopericytoma of the central nervous system.

Authors:  Deborah Boyett; Connor J Kinslow; Samuel S Bruce; Adam M Sonabend; Ali I Rae; Guy M McKhann; Michael B Sisti; Jeffrey N Bruce; Simon K Cheng; Tony J C Wang
Journal:  J Neurooncol       Date:  2019-05-03       Impact factor: 4.130

8.  Descriptive epidemiology of malignant and nonmalignant primary spinal cord, spinal meninges, and cauda equina tumors, United States, 2004-2007.

Authors:  Linh M Duong; Bridget J McCarthy; Roger E McLendon; Therese A Dolecek; Carol Kruchko; Lynda L Douglas; Umed A Ajani
Journal:  Cancer       Date:  2012-01-03       Impact factor: 6.860

9.  Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

Authors:  S Cha; J M Lupo; M-H Chen; K R Lamborn; M W McDermott; M S Berger; S J Nelson; W P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2007 Jun-Jul       Impact factor: 3.825

10.  Genetic epidemiology of glioblastoma multiforme: confirmatory and new findings from analyses of human leukocyte antigen alleles and motifs.

Authors:  Wei Song; Avima M Ruder; Liangyuan Hu; Yufeng Li; Rong Ni; Wenshuo Shao; Richard A Kaslow; MaryAnn Butler; Jianming Tang
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.